Introduction: Epitope mimicry as a component cause of autoimmune disease J. M. Davies* Pages: 523 - 526
Current cases in which epitope mimicry is considered a component cause of autoimmune disease: Guillain-Barré syndrome N. Yuki Pages: 527 - 533
Current cases in which epitope mimicry is considered as a component cause of autoimmune disease: immune-mediated (type 1) diabetes A. KukrejaN. K. Maclaren* Pages: 534 - 541
Molecular mimicry: a critical look at exemplary instances in human diseases N. R. Rose*I. R. Mackay Pages: 542 - 551
Evidence for mimicry by viral antigens in animal models of autoimmune disease including myocarditis C. M. Lawson Pages: 552 - 560
Molecular mimicry and the role of B lymphocytes in the processing of autoantigens B. LiangM. J. Mamula* Pages: 561 - 568
Epitope mimics and determinant spreading: pathways to autoimmunity A. D. FarrisC. L. KeechJ. McCluskey* Pages: 569 - 578
Tachykinins in regulation of gastric motility and secretion P. T. SchmidtJ. J. Holst* Pages: 579 - 588
Ras-related and MAPK signalling in neuronal plasticity and memory formation C. MazzucchelliR. Brambilla* Pages: 604 - 611
Nitric oxide can inhibit apoptosis or switch it into necrosis G. Melino*M. V. CataniF. Bernassola Pages: 612 - 622
The metabotropic GABA receptor: molecular insights and their functional consequences S. BleinE. Hawrot*P. Barlow Pages: 635 - 650
The structure and function of initiation factors in eukaryotic protein synthesis T. V. Pestova*C. U. T. Hellen Pages: 651 - 674
Conformational dynamics of the β2-microglobulin C terminal in the cell-membrane-anchored major histocompatibility complex type I M. MassaP. MangioneV. Bellotti* Pages: 675 - 683
